USP, through the International Training Program (ITP), provides an open forum of discussion in which our processes and approaches to developing public quality standards can be shared with regulatory agencies and reference laboratories around the world. As part of this year’s program we hosted – among others – scientific experts from the Russian Federation.
Like most African countries, the challenges facing the Zambian pharmaceutical industry are vast. But under the leadership of Ms. Esnart Mwape, Director General of the Zambia Medicines Regulatory Authority, challenges such as counterfeit drugs are being addressed, as the Authority respositions itself to take charge of the market. Read more.
Mandela Washington Fellow, Dr. Ashiru Abubakar, talks with USP about the drug supply chain, the intersection of public health and political will, and the hope for a future free of counterfeit medicines in his native Nigeria.